Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Patent
1996-07-30
1998-06-02
Wilson, James O.
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
536 2852, 536 275, C07H 100
Patent
active
057602107
ABSTRACT:
The present invention is directed toward a novel process of preparing 2'-exocyclic vinylfluoride derivatives of cytidine analogues for use as ribonucleotide reductase inhibitors.
REFERENCES:
patent: 5047520 (1991-09-01), Matsuda et al.
patent: 5378693 (1995-01-01), McCarthy et al.
patent: 5589587 (1996-12-01), McCarthy et al.
McCarthy, et al., J. of the American Chemical Society 113(19); 7439-7440 (1991).
Takenuki, et al., J. Med. Chem. 31: 1064-1066 (1988).
McCarthy, et al., Tetrahedron Letters 31(38):5449-5452 (1990).
Sabol, et al., Tetrahedron Letters 33(22):3101-3104 (1992).
Matsuda, et al., Chem. Pharm. Bull. 36(3):945-953 (1988).
Markiewicz et al., Tetrahedron Letters, vol. 29, No. 13:1561-1564 (1988).
Donaldson Richard E.
Duguid Robert
Matthews Donald P.
McCarthy James R.
McConnell James R.
Lentz Nelsen L.
Merrell Pharmaceuticals Inc.
Nelligan Mark C.
Wilson James O.
LandOfFree
Process for the preparation of ribonucleotide reductase inhibito does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for the preparation of ribonucleotide reductase inhibito, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for the preparation of ribonucleotide reductase inhibito will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1461347